دورية أكاديمية
Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of Candida glabrata : An Immunoinformatics Approach.
العنوان: | Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of Candida glabrata : An Immunoinformatics Approach. |
---|---|
المؤلفون: | Elamin Elhasan LM; Faculty of Science and Technology, Department of Biotechnology, Omdurman Islamic University, Khartoum, Sudan., Hassan MB; Faculty of Medicine and Health Science, Omdurman Islamic University, Khartoum, Sudan., Elhassan RM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sudan International University, Khartoum, Sudan., Abdelrhman FA; Department of Biotechnology, Africa City of Technology, Khartoum, Sudan., Salih EA; Biology and Technology Department, College of Applied and Industrial Sciences, University of Bahri, Khartoum, Sudan., Ibrahim H A; Faculty of Pharmacy, National Ribat University, Khartoum, Sudan., Mohamed AA; Al-Neelain Medical Research Center, Al-Neelain University, Khartoum, Sudan., Osman HS; Faculty of Medicine and Health Science, Omdurman Islamic University, Khartoum, Sudan., Khalil MSM; Al-Neelain Medical Research Center, Al-Neelain University, Khartoum, Sudan., Alsafi AA; Faculty of Science and Technology, Department of Biotechnology, Omdurman Islamic University, Khartoum, Sudan., Idris AB; Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan., Hassan MA; Department of Biotechnology, Africa City of Technology, Khartoum, Sudan.; Department of Translation Bioinformatics, Detavax Biotech, Kayseri, Turkey. |
المصدر: | Journal of immunology research [J Immunol Res] 2021 May 04; Vol. 2021, pp. 8280925. Date of Electronic Publication: 2021 May 04 (Print Publication: 2021). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101627166 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-7156 (Electronic) Linking ISSN: 23147156 NLM ISO Abbreviation: J Immunol Res Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Cairo, Egypt : Hindawi Publishing Corporation, [2014]- |
مواضيع طبية MeSH: | Candida glabrata/*immunology , Candidiasis/*therapy , Fructose-Bisphosphate Aldolase/*immunology , Fungal Proteins/*immunology , Fungal Vaccines/*immunology, Amino Acid Sequence/genetics ; Candida glabrata/enzymology ; Candida glabrata/genetics ; Candidiasis/immunology ; Candidiasis/microbiology ; Computational Biology ; Conserved Sequence/genetics ; Conserved Sequence/immunology ; Drug Design ; Epitope Mapping/methods ; Epitopes, B-Lymphocyte/genetics ; Epitopes, B-Lymphocyte/immunology ; Epitopes, T-Lymphocyte/genetics ; Epitopes, T-Lymphocyte/immunology ; Fructose-Bisphosphate Aldolase/genetics ; Fructose-Bisphosphate Aldolase/metabolism ; Fungal Proteins/genetics ; Fungal Proteins/metabolism ; Fungal Vaccines/administration & dosage ; Fungal Vaccines/genetics ; Histocompatibility Antigens Class I/immunology ; Histocompatibility Antigens Class I/metabolism ; Histocompatibility Antigens Class I/ultrastructure ; Histocompatibility Antigens Class II/immunology ; Histocompatibility Antigens Class II/metabolism ; Histocompatibility Antigens Class II/ultrastructure ; Humans ; Immunogenicity, Vaccine/genetics ; Molecular Docking Simulation ; Protein Structure, Tertiary ; Vaccines, Subunit/administration & dosage ; Vaccines, Subunit/genetics ; Vaccines, Subunit/immunology |
مستخلص: | Background: Candida glabrata is a human opportunistic pathogen that can cause life-threatening systemic infections. Although there are multiple effective vaccines against fungal infections and some of these vaccines are engaged in different stages of clinical trials, none of them have yet been approved by the FDA. Aim: Using immunoinformatics approach to predict the most conserved and immunogenic B- and T-cell epitopes from the fructose bisphosphate aldolase (Fba1) protein of C. glabrata . Material and Method . 13 C. glabrata fructose bisphosphate aldolase protein sequences (361 amino acids) were retrieved from NCBI and presented in several tools on the IEDB server for prediction of the most promising epitopes. Homology modeling and molecular docking were performed. Result: The promising B-cell epitopes were AYFKEH, VDKESLYTK, and HVDKESLYTK, while the promising peptides which have high affinity to MHC I binding were AVHEALAPI, KYFKRMAAM, QTSNGGAAY, RMAAMNQWL, and YFKEHGEPL. Two peptides, LFSSHMLDL and YIRSIAPAY, were noted to have the highest affinity to MHC class II that interact with 9 alleles. The molecular docking revealed that the epitopes QTSNGGAAY and LFSSHMLDL have the lowest binding energy to MHC molecules. Conclusion: The epitope-based vaccines predicted by using immunoinformatics tools have remarkable advantages over the conventional vaccines in that they are more specific, less time consuming, safe, less allergic, and more antigenic. Further in vivo and in vitro experiments are needed to prove the effectiveness of the best candidate's epitopes (QTSNGGAAY and LFSSHMLDL). To the best of our knowledge, this is the first study that has predicted B- and T-cell epitopes from the Fba1 protein by using in silico tools in order to design an effective epitope-based vaccine against C. glabrata . Competing Interests: The authors declare that there are no conflicts of interest. (Copyright © 2021 Lina Mohamed Elamin Elhasan et al.) |
References: | Med Mycol. 2012 Feb;50(2):143-51. (PMID: 21728753) Protein Sci. 2003 May;12(5):1007-17. (PMID: 12717023) Cell Microbiol. 2013 May;15(5):701-8. (PMID: 23253282) Microb Pathog. 2017 Jun;107:293-303. (PMID: 28396240) Res Vet Sci. 2019 Jun;124:70-78. (PMID: 30852357) Value Health. 2002 Jan-Feb;5(1):26-34. (PMID: 11873380) Int Rev Immunol. 2019;38(6):307-322. (PMID: 31478759) Biomed Pharmacother. 2019 Jan;109:333-344. (PMID: 30399567) Nat Protoc. 2012 Jul 19;7(8):1511-22. (PMID: 22814390) Ther Clin Risk Manag. 2014 Feb 13;10:95-105. (PMID: 24611015) FEBS Lett. 1990 Dec 10;276(1-2):172-4. (PMID: 1702393) J Fungi (Basel). 2018 May 20;4(2):. (PMID: 29783771) Eukaryot Cell. 2006 Aug;5(8):1371-7. (PMID: 16896220) N Engl J Med. 2014 Mar 27;370(13):1198-208. (PMID: 24670166) Biophys J. 2015 May 5;108(9):2097-102. (PMID: 25954868) Immunome Res. 2006 Apr 24;2:2. (PMID: 16635264) J Med Microbiol. 2003 Aug;52(Pt 8):615-622. (PMID: 12867553) J Microbiol. 2010 Jun;48(3):365-71. (PMID: 20571955) J Comput Chem. 2004 Oct;25(13):1605-12. (PMID: 15264254) Microb Pathog. 2015 Oct;87:1-12. (PMID: 26188289) J Struct Biol. 2012 Sep;179(3):269-78. (PMID: 21963794) Bioinformatics. 2008 Jun 1;24(11):1397-8. (PMID: 18413329) Bioinform Biol Insights. 2018 Nov 12;12:1177932218809703. (PMID: 30542244) Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W509-12. (PMID: 18463140) Int J Mol Med. 2016 Apr;37(4):1127-38. (PMID: 26935978) Bioinformatics. 2015 May 1;31(9):1484-6. (PMID: 25540183) Clin Microbiol Rev. 2007 Jan;20(1):133-63. (PMID: 17223626) Exp Ther Med. 2018 Mar;15(3):2374-2380. (PMID: 29456643) Biochem J. 1992 Sep 1;286 ( Pt 2):313-30. (PMID: 1530563) Perit Dial Int. 2012 Jan-Feb;32(1):114-5. (PMID: 22302932) J Immunol Res. 2020 Nov 5;2020:9475058. (PMID: 33204735) J Fungi (Basel). 2018 Sep 01;4(3):. (PMID: 30200517) FEMS Yeast Res. 2014 Jun;14(4):529-35. (PMID: 24528571) Future Virol. 2012 Nov 1;7(11):1077-1088. (PMID: 23630544) Genome Med. 2015 Nov 20;7:119. (PMID: 26589500) Trends Biotechnol. 2006 Dec;24(12):537-8. (PMID: 17045685) Eukaryot Cell. 2008 Nov;7(11):1951-64. (PMID: 18806209) Nature. 2004 Jul 1;430(6995):35-44. (PMID: 15229592) Bioinformatics. 2016 Feb 15;32(4):511-7. (PMID: 26515819) Nucleic Acids Res. 2003 Jul 1;31(13):3784-8. (PMID: 12824418) Nucleic Acids Res. 2012 Jul;40(Web Server issue):W288-93. (PMID: 22581768) Med Mycol. 2019 Aug 1;57(6):745-756. (PMID: 30521033) FEMS Immunol Med Microbiol. 2011 Jul;62(2):215-24. (PMID: 21535228) FEBS Lett. 1991 Nov 18;293(1-2):97-100. (PMID: 1959676) Nucleic Acids Res. 2015 Jan;43(Database issue):D405-12. (PMID: 25300482) Proteomics. 2009 Apr;9(8):2230-52. (PMID: 19322777) PLoS One. 2013 Jul 23;8(7):e69664. (PMID: 23936069) BMC Genomics. 2013 Sep 14;14:623. (PMID: 24034898) Clin Infect Dis. 2012 Nov 15;55(10):1352-61. (PMID: 22893576) Tissue Antigens. 2003 Nov;62(5):378-84. (PMID: 14617044) Eur J Biochem. 1989 Mar 15;180(2):301-8. (PMID: 2647491) FEMS Yeast Res. 2009 Oct;9(7):1013-28. (PMID: 19624749) N Engl J Med. 2015 Oct 8;373(15):1445-56. (PMID: 26444731) Clin Dev Immunol. 2008;2008:721950. (PMID: 18382617) J Virol. 1985 Sep;55(3):836-9. (PMID: 2991600) J Fungi (Basel). 2018 Jun 05;4(2):. (PMID: 29874814) J Proteome Res. 2016 May 6;15(5):1418-34. (PMID: 27048922) BMC Bioinformatics. 2006 Mar 17;7:153. (PMID: 16545123) Med Mycol. 2007 Jun;45(4):321-46. (PMID: 17510856) Mol Microbiol. 2011 Mar;79(6):1574-93. (PMID: 21269335) Trends Biochem Sci. 1992 Mar;17(3):110-3. (PMID: 1412694) Microb Pathog. 2016 Jan;90:22-33. (PMID: 26550764) FEMS Microbiol Rev. 2012 Mar;36(2):288-305. (PMID: 21569057) Microb Pathog. 2018 Nov;124:230-237. (PMID: 30142464) Emerg Infect Dis. 2014 Jul;20(7):1149-55. (PMID: 24960557) Antimicrob Agents Chemother. 2018 May 25;62(6):. (PMID: 29581112) FEMS Yeast Res. 2015 Aug;15(5):fov042. (PMID: 26066553) BMC Struct Biol. 2007 Oct 02;7:64. (PMID: 17910770) Crit Rev Microbiol. 2016 Nov;42(6):905-27. (PMID: 26690853) J Biomed Biotechnol. 2010;2010:765762. (PMID: 21772788) Protein Sci. 2006 Nov;15(11):2558-67. (PMID: 17001032) Microb Pathog. 2018 Nov;124:21-29. (PMID: 30118801) BMC Bioinformatics. 2009 Sep 18;10:296. (PMID: 19765293) BMC Bioinformatics. 2008 Dec 02;9:514. (PMID: 19055730) J Chem Theory Comput. 2014 Oct 14;10(10):4745-58. (PMID: 26588162) |
المشرفين على المادة: | 0 (Epitopes, B-Lymphocyte) 0 (Epitopes, T-Lymphocyte) 0 (Fungal Proteins) 0 (Fungal Vaccines) 0 (Histocompatibility Antigens Class I) 0 (Histocompatibility Antigens Class II) 0 (Vaccines, Subunit) EC 4.1.2.13 (Fructose-Bisphosphate Aldolase) |
تواريخ الأحداث: | Date Created: 20210526 Date Completed: 20211129 Latest Revision: 20220423 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC8116159 |
DOI: | 10.1155/2021/8280925 |
PMID: | 34036109 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2314-7156 |
---|---|
DOI: | 10.1155/2021/8280925 |